Skip Navigation
  Search Menu
Find an Expert

 

Catherine Handy Marshall, M.D., M.P.H.

Photo of Dr. Catherine Handy Marshall, M.D., M.P.H.

Assistant Chief of Service, Osler Medical Housestaff Training Program

Assistant Professor of Oncology

Female

Expertise: Internal Medicine, Oncology

Research Interests: Prostate cancer; cancer and cardiovascular disease

Locations

The Johns Hopkins Hospital

600 North Wolfe Street Harvey Building, Room 808 Baltimore, MD 21287 map

Phone: 410-955-7911 | Fax: 410-955-0374

Skip Viragh Outpatient Cancer Center

APPOINTMENT PHONE: 410-955-8964

201 N. Broadway Baltimore, MD 21287 map

Phone: 410-955-8893

Background

Dr. Catherine Marshall is an Assistant Professor in the Department of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine and oncology.

She received her M.D. and M.P.H. from Johns Hopkins, where she also completed her residency and an oncology fellowship. She previously served as an Assistant Chief of Service for the Osler Medical Housestaff Training Program.

...read more

Titles

  • Assistant Chief of Service, Osler Medical Housestaff Training Program
  • Assistant Professor of Oncology

Departments / Divisions

Education

Degrees

  • MD, Johns Hopkins University School of Medicine (2012)

Residencies

  • Johns Hopkins University School of Medicine / Internal Medicine (2015)

Fellowships

  • Johns Hopkins University School of Medicine / Oncology (2016)
  • Johns Hopkins University School of Medicine / Oncology (2019)

Board Certifications

  • American Board of Internal Medicine / Internal Medicine (2015)
  • Pending/Scheduled / Oncology (2018)

Research & Publications

Research Summary

Dr. Handy’s research focuses on the relationship between coronary calcium buildup and diseases including cancer, heart disease, kidney disease and lung disease.

Selected Publications

View all on Pubmed

Marshall CH, Fu W, Wang H, Baras AS, Lotan TL, Antonarakis ES. Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage. Prostate Cancer Prostatic Dis. 2018 Aug 31. doi: 10.1038/s41391-018-0086-1. [Epub ahead of print] PubMed PMID: 30171229.

Handy CE, Quispe R, Pinto X, Blaha MJ, Blumenthal RS, Michos ED, Lima JAC, Guallar E, Ryu S, Cho J, Kaye JA, Comin-Colet J, Corbella X, Cainzos-Achirica M. Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment. Circulation. 2018 Aug 14;138(7):727-734. doi: 10.1161/CIRCULATIONAHA.118.035516. PubMed PMID: 30359131.

Handy CE, Antonarakis ES. Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions. Future Oncol. 2018 Apr;14(10):907-917. doi: 10.2217/fon-2017-0531. Epub 2017 Dec 20. Review. PubMed PMID: 29260582; PubMed Central PMCID: PMC5925432.

Handy CE, Antonarakis ES. Sequencing Treatment for Castration-Resistant Prostate Cancer. Curr Treat Options Oncol. 2016 Dec;17(12):64. Review. PubMed PMID: 27822685.

Handy Marshall C, Nahas-Vigon J, Manesh R, Gelber AC. Just Beneath the Surface. N Engl J Med. 2018 Sep 6;379(10):968-973. doi: 10.1056/NEJMcps1802664. PubMed PMID: 30184453.

Activities & Honors

Honors

  • Blumenthal Award, Johns Hopkins University School of Medicine, 2015

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 

Comments

Loading...
Is this you? Edit Profile